Optos plc (OPTS) - Product Pipeline Analysis, 2015 Update

Date: April 10, 2015
Pages: 26
US$ 750.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)

Download PDF Leaflet

Optos plc (OPTS) - Product Pipeline Analysis, 2015 Update

Optos plc (Optos) is a medical technology company dealing with manufacture and marketing of retinal imaging devices. It offers ultra wide field and high resolution retinal imaging devices for early detection of ophthalmic conditions like retinal detachment, glaucoma, cataracts, retinal holes/retinal tears and age-related macular degeneration. The company’s ultra-widefield technology in synergy with integrated optical coherence tomography (OCT) provides a combination of wide-field retinal imaging for the practitioner and patient. The company divided its products into three categories, namely, diagnostic, image management, and treatment devices. It operates in the US, Canada, Germany, Switzerland, Norway, Sweden, Spain and France. Optos is headquartered in Scotland, the UK.The company focuses on innovation and development of the front-end businesses to differentiate its offerings. It also prioritizes on long-term investments in technology and systems to execute its succession plans. In addition, it is involved in geographical expansion initiatives to tap high value multinational clients.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Optos plc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Optos plc Company Snapshot
Optos plc Company Overview
Key Information
Optos plc Pipeline Products and Clinical Trials Overview
Optos plc – Pipeline Analysis Overview
Business Description
Key Facts
Optos plc - Major Products and Services
Optos plc Pipeline Products by Development Stage
Optos plc Pipeline Products Overview



Early Detection Device - Eye Disease
Early Detection Device - Eye Disease Product Overview
Lotte Product Overview
Optos plc - Key Competitors
Optos plc - Key Employees
Optos plc - Key Employee Biographies
Optos plc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Optos plc, Recent Developments
Nov 19, 2014: OPTOS Preliminary Results FY14
Oct 20, 2014: Optos unveils California, its next generation ultra-wide imaging device for the ophthalmology market
May 15, 2014: Optos Announces Interim Results for the six months to 31 March 2014
Mar 10, 2014: Oxford Pharma appoints John Goddard as non-executive director
Nov 15, 2013: Optos to announce results for the year ended 30 September 2013 on 21 November 2013
Oct 16, 2013: Optos Appoints Rob Kennedy As CFO
Jul 18, 2013: Optos Appoints Louisa Burdett As Interim CFO
Mar 11, 2013: Optos Receives FDA 510(k) Clearance For Microperimetry
May 17, 2012: Optos Reports Revenue Of $86.2m In H1 Fiscal 2012
Nov 22, 2011: Optos Reports Revenue Of $143.3m In Fiscal 2011
About GlobalData
Contact Us


Optos plc, Key Facts
Optos plc Pipeline Products and Clinical Trials Overview
Optos plc Pipeline Products by Equipment Type
Optos plc Pipeline Products by Indication
Optos plc, Key Facts
Optos plc, Major Products and Services
Optos plc Number of Pipeline Products by Development Stage
Optos plc Pipeline Products Summary by Development Stage



Early Detection Device - Eye Disease - Product Status
Early Detection Device - Eye Disease - Product Description
Lotte - Product Status
Lotte - Product Description
Optos plc, Key Employees
Optos plc, Key Employee Biographies
Optos plc, Other Locations
Optos plc, Subsidiaries


Optos plc Pipeline Products by Equipment Type
Optos plc Pipeline Products by Development Stage
Skip to top

Ask Your Question

Optos plc (OPTS) - Product Pipeline Analysis, 2015 Update
Company name*:
Contact person*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: